TEVA-DILTIAZEM XC

Identification of Teva-Diltiazem Xc

No description

Google image searchProduct monograph

Active ingredient

diltiazem hydrochloride, 180 MG

DIN: 02429322

Dosage form(s): TABLET (EXTENDED-RELEASE)

Route(s) of administration: ORAL

Schedule: Prescription

Company: TEVA CANADA LIMITED

Date: 27-JUN-2022

ATC:

• C08 — CALCIUM CHANNEL BLOCKERS (ATC, ATC/DDD, )
• C08D — SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS (ATC, ATC/DDD)
• C08DB — Benzothiazepine derivatives (ATC, ATC/DDD)
• C08DB01 — DILTIAZEM (ATC/DDD)

Reference brand drug: Cardizem, Tiazac

Pharmaceutical standard: MFR

External Links for Teva-Diltiazem Xc

Search on Google

• Teva-Diltiazem Xc side effects
• Teva-Diltiazem Xc dosage
• diltiazem hydrochloride side effects
• diltiazem hydrochloride dosage

Teva Canada Limited

Go to Teva website to see drug product details. Sometimes you can find teva-diltiazem xc photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.